FI20022048A0 - Ei-kompetetiivinen immunomääritys pienille analyyteille - Google Patents

Ei-kompetetiivinen immunomääritys pienille analyyteille

Info

Publication number
FI20022048A0
FI20022048A0 FI20022048A FI20022048A FI20022048A0 FI 20022048 A0 FI20022048 A0 FI 20022048A0 FI 20022048 A FI20022048 A FI 20022048A FI 20022048 A FI20022048 A FI 20022048A FI 20022048 A0 FI20022048 A0 FI 20022048A0
Authority
FI
Finland
Prior art keywords
analyte
small
competitive immunoassay
assays
binding partner
Prior art date
Application number
FI20022048A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Timo Pulli
Matti Hoeyhtyae
Kristiina Takkinen
Hans Soederlund
Original Assignee
Valtion Teknillinen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valtion Teknillinen filed Critical Valtion Teknillinen
Priority to FI20022048A priority Critical patent/FI20022048A0/fi
Publication of FI20022048A0 publication Critical patent/FI20022048A0/fi
Priority to AU2003282143A priority patent/AU2003282143B2/en
Priority to EP03773761A priority patent/EP1579222B8/fr
Priority to PCT/FI2003/000875 priority patent/WO2004046733A1/fr
Priority to DK03773761T priority patent/DK1579222T3/da
Priority to MXPA05005288A priority patent/MXPA05005288A/es
Priority to CN2003801034664A priority patent/CN1711476B/zh
Priority to NZ539714A priority patent/NZ539714A/en
Priority to US10/535,260 priority patent/US7749712B2/en
Priority to BRPI0316384A priority patent/BRPI0316384B8/pt
Priority to CA2503509A priority patent/CA2503509C/fr
Priority to AT03773761T priority patent/ATE408146T1/de
Priority to EA200500643A priority patent/EA200500643A1/ru
Priority to JP2004552756A priority patent/JP4729701B2/ja
Priority to DE60323538T priority patent/DE60323538D1/de
Priority to ES03773761T priority patent/ES2312828T3/es
Priority to ZA200503475A priority patent/ZA200503475B/en
Priority to NO20052849A priority patent/NO338417B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. ***e, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format
    • G01N2470/06—Second binding partner specifically binding complex of analyte with first binding partner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Wrappers (AREA)
FI20022048A 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille FI20022048A0 (fi)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FI20022048A FI20022048A0 (fi) 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille
ES03773761T ES2312828T3 (es) 2002-11-18 2003-11-17 Inmunoensayo no competitivo para analitos pequeños.
US10/535,260 US7749712B2 (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
CA2503509A CA2503509C (fr) 2002-11-18 2003-11-17 Dosage immunologique non competitif pour substances a analyser de taille reduite
PCT/FI2003/000875 WO2004046733A1 (fr) 2002-11-18 2003-11-17 Dosage immunologique non competitif pour substances a analyser de taille reduite
DK03773761T DK1579222T3 (da) 2002-11-18 2003-11-17 Ikke-kompetitivt immunassay til små analytter
MXPA05005288A MXPA05005288A (es) 2002-11-18 2003-11-17 Inmunoanalisis no competitivo para analitos pequenos.
CN2003801034664A CN1711476B (zh) 2002-11-18 2003-11-17 小分析物的非竞争性免疫测定
NZ539714A NZ539714A (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
AU2003282143A AU2003282143B2 (en) 2002-11-18 2003-11-17 Non-competitive immunoassay for small analytes
BRPI0316384A BRPI0316384B8 (pt) 2002-11-18 2003-11-17 imunoensaio não competitivo para analitos pequenos
EP03773761A EP1579222B8 (fr) 2002-11-18 2003-11-17 Dosage immunologique non competitif pour substances a analyser de taille reduite
AT03773761T ATE408146T1 (de) 2002-11-18 2003-11-17 Nichtkompetitiver immunassay für kleine analyten
EA200500643A EA200500643A1 (ru) 2002-11-18 2003-11-17 Способ неконкурентного иммуноанализа для определения малых аналитов
JP2004552756A JP4729701B2 (ja) 2002-11-18 2003-11-17 小さな分析物のための非競合的な免疫アッセイ法
DE60323538T DE60323538D1 (de) 2002-11-18 2003-11-17 Nichtkompetitiver immunassay für kleine analyten
ZA200503475A ZA200503475B (en) 2002-11-18 2005-04-29 Non-competetive immunoassay for small analytes
NO20052849A NO338417B1 (no) 2002-11-18 2005-06-13 Ikke-kompetitiv immunoassay for små analytter.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20022048A FI20022048A0 (fi) 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille

Publications (1)

Publication Number Publication Date
FI20022048A0 true FI20022048A0 (fi) 2002-11-18

Family

ID=8564953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20022048A FI20022048A0 (fi) 2002-11-18 2002-11-18 Ei-kompetetiivinen immunomääritys pienille analyyteille

Country Status (17)

Country Link
US (1) US7749712B2 (fr)
EP (1) EP1579222B8 (fr)
JP (1) JP4729701B2 (fr)
CN (1) CN1711476B (fr)
AT (1) ATE408146T1 (fr)
BR (1) BRPI0316384B8 (fr)
CA (1) CA2503509C (fr)
DE (1) DE60323538D1 (fr)
DK (1) DK1579222T3 (fr)
EA (1) EA200500643A1 (fr)
ES (1) ES2312828T3 (fr)
FI (1) FI20022048A0 (fr)
MX (1) MXPA05005288A (fr)
NO (1) NO338417B1 (fr)
NZ (1) NZ539714A (fr)
WO (1) WO2004046733A1 (fr)
ZA (1) ZA200503475B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109067A1 (en) 2001-12-06 2003-06-12 Immunetech, Inc. Homogeneous immunoassays for multiple allergens
JP2007040834A (ja) * 2005-08-03 2007-02-15 Japan Science & Technology Agency 免疫測定用試薬
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
GB0707870D0 (en) * 2007-04-23 2007-05-30 Selected Antibodies Ltd Assay Devices and Methods and Components for use Therein
ES2373009T3 (es) * 2007-12-18 2012-01-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Morfina endógena o un metabolito de origen natural de la misma como marcador para septicemia.
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
ES2443065T3 (es) * 2008-04-02 2014-02-17 Vivacta Limited Un método para detectar una sustancia química
US8093018B2 (en) 2008-05-20 2012-01-10 Otsuka Pharmaceutical Co., Ltd. Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same
FI20085579A0 (fi) * 2008-06-12 2008-06-12 Valtion Teknillinen Kannabiskäytön toteaminen
DE102008049601A1 (de) * 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
CA2739310C (fr) * 2009-07-21 2014-07-08 Sekisui Medical Co., Ltd. Procede de mesure du niveau d'insuline
EP2493507A4 (fr) * 2009-10-30 2013-11-20 Merck Sharp & Dohme Antagonistes et variants ax213 et ax132 pcsk9
WO2011061944A1 (fr) * 2009-11-19 2011-05-26 株式会社プロテイン・エクスプレス Procédé de dosage fluoroimmunologique
US8883978B2 (en) 2010-05-11 2014-11-11 Institute For Cancer Research Antibodies to tumor endothelial marker 7R
IN2014CN02113A (fr) * 2011-09-21 2015-05-29 Fujirebio Kk
WO2013059805A1 (fr) * 2011-10-21 2013-04-25 Decimadx, Llc Tests de point de soins de detection immunologique pour mesurer quantitativement de petits analytes
EP2637021A1 (fr) 2012-03-06 2013-09-11 Securetec Detektions-Systeme AG Procédé et dispositif destinés à la vérification d'analytes
US9804161B1 (en) * 2012-05-14 2017-10-31 Lawrence Livermore National Security, Llc Detector and related, devices, methods and systems
EP2722669A1 (fr) 2012-10-22 2014-04-23 Securetec Detektions-Systeme AG Procédé et dispositif destinés à la vérification de drogues illégales
JP6673895B2 (ja) 2014-03-21 2020-03-25 エスティー アンド ティー インターナショナル，インコーポレイティド アサ属抽出方法及び組成物
FI126746B (en) 2014-04-07 2017-05-15 Teknologian Tutkimuskeskus Vtt Oy Antibody to HT-2 toxin-HT-2 toxin antibody complex
US11001872B2 (en) * 2015-09-22 2021-05-11 Shawn Clark Designing customized protein-specific buffer system
ES2923755T3 (es) 2015-10-23 2022-09-30 Fred Hutchinson Cancer Center Procedimientos para crear sistemas de proteínas de dimerización inducidos químicamente para la regulación de eventos celulares
AU2016378819C1 (en) 2015-12-21 2022-06-16 Turun Yliopisto Antibodies against immunocomplexes comprising cyanobacterial cyclic peptide hepatotoxins
AU2017209523A1 (en) * 2016-01-22 2018-08-09 Affimedix, Inc. Device for detection of vitamin D metabolites
JP7177767B2 (ja) * 2016-07-29 2022-11-24 ダイアザイム ラボラトリーズ， インコーポレイテッド ビタミンｄをアッセイするための方法および組成物
IL294218A (en) 2019-12-27 2022-08-01 Chiome Bioscience Inc Antibody against cdcp1
JPWO2022049867A1 (fr) 2020-09-02 2022-03-10
WO2023102201A2 (fr) * 2021-12-03 2023-06-08 University Of Utah Research Foundation Domaines de liaison à l'antigène cd229 hautement sélectifs et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
WO1995027045A1 (fr) * 1994-03-30 1995-10-12 Igen, Inc. Isolement et production d'anticorps catalytiques par une technologie faisant appel a des phages
JP3025633B2 (ja) * 1995-12-05 2000-03-27 株式会社蛋白工学研究所 グルタチオン結合活性を有するポリペプチド及びその製造方法
JP4228095B2 (ja) 1999-12-17 2009-02-25 東ソー株式会社 免疫測定方法および免疫測定試薬
CN1136450C (zh) * 2000-11-03 2004-01-28 厦门大学 具有荧光共振能量转移特征的成对蛋白及其用途

Also Published As

Publication number Publication date
CN1711476B (zh) 2010-09-08
EA200500643A1 (ru) 2005-12-29
CA2503509C (fr) 2013-02-05
BR0316384A (pt) 2005-10-04
EP1579222A1 (fr) 2005-09-28
NO338417B1 (no) 2016-08-15
US20060246506A1 (en) 2006-11-02
DK1579222T3 (da) 2008-11-17
BRPI0316384B1 (pt) 2016-07-05
ES2312828T3 (es) 2009-03-01
WO2004046733A1 (fr) 2004-06-03
CN1711476A (zh) 2005-12-21
NO20052849L (no) 2005-06-13
ATE408146T1 (de) 2008-09-15
BRPI0316384B8 (pt) 2021-07-27
MXPA05005288A (es) 2005-08-16
US7749712B2 (en) 2010-07-06
EP1579222B8 (fr) 2009-01-07
NZ539714A (en) 2007-03-30
JP4729701B2 (ja) 2011-07-20
DE60323538D1 (de) 2008-10-23
AU2003282143A1 (en) 2004-06-15
CA2503509A1 (fr) 2004-06-03
EP1579222B1 (fr) 2008-09-10
ZA200503475B (en) 2006-07-26
JP2006506634A (ja) 2006-02-23

Similar Documents

Publication Publication Date Title
NO20052849L (no) Ikke-kompetitiv immunoassay for sma analytter.
WO2002090983A3 (fr) Test immunologique quantitatif en une seule etape, se presentant sous forme lyophilisee
WO2007035633A3 (fr) Techniques et procedes de criblage
WO2006086208A3 (fr) Dosage immunologique de 5-fluoro-uracil
EP2434286A3 (fr) Réactifs pour dosage immunologique et leurs procédés d'utilisation
WO2007040559A3 (fr) Dosage par electrochimiluminescence
CA2573749A1 (fr) Element de test immunologique avec zone temoin amelioree
DE602004001533D1 (de) Immunotestverfahren für Herz-Troponin I
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
ATE447712T1 (de) Immunoassay mit doppelter standardkurve
ATE374944T1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
WO2007054714A3 (fr) Analyse par agglutination
EP1072888A3 (fr) Méthode et réactif d'immunoessai pour l'antigène HIV-1p24
NO20052553L (no) Cobalaminanalyse.
WO2006020263A3 (fr) Anticorps vis-a-vis du cytoxane et immunoessai
ATE502300T1 (de) Immunoassay-verfahren
WO2001063285A3 (fr) Procede de detection de helicobacter pylori et heilmanii dans des echantillons de selles et de salive et dans de la matiere de biopsie
ATE108907T1 (de) Bestimmungsverfahren, seine verwendung und komponenten.
WO2006138694A3 (fr) Anticorps monoclonal de lapin dirige contre la proteine id1
YU164090A (sh) Postopek za dokazovanje analitov
DE60122306D1 (de) Antikörper, die spezifisch für freies inaktives psa sind, und ihre verwendungen
ATE437362T1 (de) Ig-assay
YU56001A (sh) Postupak semikvantitativne adsorpcije antitela prema blastokonidijama candida albicans